de Ville de Goyet J, Hausleithner V, Malaise J, Reding R, Lerut J, Jamart J, Barker A, Otte J B
Department of Surgery, Cliniques St. Luc, University of Louvain Medical School, Brussels.
Transplantation. 1994 May 15;57(9):1328-32. doi: 10.1097/00007890-199405150-00007.
The outcome after liver transplantation when grafts were retrieved from the donor by the classical aortic and portal cooling (APC) method was compared with the outcome when exclusively aortic in situ perfusion (AC) was used. Retrospectively, 163 donor hepatectomies performed over a 20-month period were reviewed to analyze overall graft (APC n = 78, AC n = 85) and patient outcome. The global graft and patient survival rates were not significantly lower in the APC group, except for 3-month graft survival (APC 72%, AC 87%; P = 0.015). However, this could be unrelated to the technique. In a subgroup of 140 cases (APC n = 64, AC n = 76), a more detailed analysis was performed. Populations of donors and recipients were similar. The graft injury and the immediate graft function were not significantly different between both groups. A multivariate analysis shows that low donor weight (P = 0.007), donor hypernatremia (P = 0.014), and in situ portal perfusion (P = 0.045) were significant determinants of a higher postoperative peak of glutamic pyruvic transaminase. In summary, in this series, routine human liver procurement using exclusive aortic perfusion seemed to be at least as safe as using a combined aortic and portal perfusion technique. This simplified method may also represent some advantages for combined pancreas and intestinal harvesting in the future.
将采用经典主动脉和门静脉降温(APC)方法从供体获取移植物后的肝移植结果与仅使用主动脉原位灌注(AC)时的结果进行比较。回顾性分析了在20个月期间进行的163例供体肝切除术,以分析总体移植物(APC组n = 78,AC组n = 85)和患者的结局。除3个月移植物存活率外(APC组72%,AC组87%;P = 0.015),APC组的总体移植物和患者存活率并无显著降低。然而,这可能与技术无关。在140例亚组病例(APC组n = 64,AC组n = 76)中进行了更详细的分析。供体和受体人群相似。两组之间的移植物损伤和即时移植物功能无显著差异。多变量分析显示,供体体重低(P = 0.007)、供体高钠血症(P = 0.014)和原位门静脉灌注(P = 0.045)是术后谷丙转氨酶峰值升高的重要决定因素。总之,在本系列研究中,采用单纯主动脉灌注进行常规人体肝脏获取似乎至少与采用主动脉和门静脉联合灌注技术一样安全。这种简化方法未来在联合胰腺和肠道获取方面可能也具有一些优势。